Skip to content

Evaluation of therapeutic outcome of ringer lactate in treatment of acute resuscitation phase of severe dehydration children a randomized clinical trial

Evaluation of therapeutic outcome of ringer lactate in treatment of acute resuscitation phase of severe dehydration children a randomized clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210201050199N2
Enrollment
104
Registered
2023-08-26
Start date
2023-08-23
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dehydration. Lack of water

Interventions

Intervention 1: Intervention group: 20 cc of Ringer's serum lactate will be injected intravenously as a bolus liquid per kilogram of weight. After initial resuscitation, patients were treated with dex

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Days to 14 Years

Inclusion criteria

Inclusion criteria: Severe dehydration Age 30 days to 14 years

Exclusion criteria

Exclusion criteria: Severe and acute malnutrition Duration of diarrhea more than 7 days The presence of blood in the stool underlying systemic disease Receiving Ringer's serum or normal saline in the last 24 hours Electrolyte disorder such as hypo or hypernatremia in the initial tests of the patient Occurrence of seizures during hospitalization

Design outcomes

Primary

MeasureTime frame
Primary outcome: comparison of the time for the disappearance of symptoms of severe dehydration. Timepoint: At the beginning and six hours after the start of treatment. Method of measurement: Clinical examination.

Secondary

MeasureTime frame
Time to resolve acidosis. Timepoint: At the beginning and six hours after the start of treatment. Method of measurement: blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactManijeh Tabrizi

Rasht University of Medical Sciences

drs.tabrizi@gmail.com+98 13 3336 9002

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026